張 維倫

Medicine & Life Sciences

1. Helicobacter pylori 100%
2. Esophageal Squamous Cell Carcinoma 92%
3. Pylorus 85%
4. Metaplasia 49%
5. Stomach 44%
6. Stomach Neoplasms 43%
7. Peptic Esophagitis 42%
8. Esomeprazole 36%
9. Chemoradiotherapy 29%
10. Levofloxacin 29%
11. spasmolytic polypeptide 28%
12. Los Angeles 27%
13. Gastritis 26%
14. Peptic Ulcer 22%
15. Neoplasms 20%
16. Helicobacter Infections 20%
17. Stomach Ulcer 18%
18. Hemorrhage 17%
19. Intensity-Modulated Radiotherapy 17%
20. Survival 16%
21. Osteopontin 16%
22. Duodenal Ulcer 16%
23. Endoscopy 16%
24. Clarithromycin 15%
25. Therapeutics 15%
26. Pantoprazole 13%
27. Esophageal Fistula 13%
28. Genotype 13%
29. Dyspepsia 12%
30. Cytochrome P-450 CYP2C19 12%
31. Fine Needle Biopsy 12%
32. Body Mass Index 12%
33. Metronidazole 11%
34. Amoxicillin 10%
35. Infections 9%
36. Integrins 9%
37. Gastroesophageal Reflux 9%
38. Carcinogenesis 9%
39. Ulcer 9%
40. Trefoil Factor-2 9%
41. Omeprazole 9%
42. Esophageal Stenosis 9%
43. DNA 8%
44. Biomarkers 8%
45. Amino Acid Sequence 8%
46. Matrix Metalloproteinase 9 8%